Shengxiang Biology: The product Yeast Pneumocystis jirovecii nucleic acid detection kit has obtained registration certificate.

Shengxiang Biological announced that the company's products Yeast Pneumocystis, New Cryptococcus, and Aspergillus nucleic acid detection kits have recently received the "Medical Device Registration Certificate" issued by the National Medical Products Administration. The registration category is the third type of in vitro diagnostic reagent in China, and the registration certificate is valid until June 19, 2030. This product is used for in vitro qualitative testing of deep-seated fungal infections in human sputum and alveolar lavage fluid, including Yeast Pneumocystis, New Cryptococcus, and Aspergillus DNA. The product uses real-time fluorescence PCR technology, covering all three major high-risk lung fungal pathogens in one test, further enriching the company's respiratory product ecosystem and providing clinical with more efficient and precise testing solutions.